TLR4 and demyelinating disease: ApTOLL is an aptamer selected to antagonize Toll-like receptor 4 (TLR4), which is involved in immunological and inflammatory reactions in demyelinating diseases like multiple sclerosis (MS) and autoimmune encephalomyelitis (EAE).